200 related articles for article (PubMed ID: 24690905)
1. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease.
Sun M; Yang P; Du L; Yang Y; Ye J
PLoS One; 2014; 9(4):e93214. PubMed ID: 24690905
[TBL] [Abstract][Full Text] [Related]
2. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.
Peng Z; Jiang S; Wu M; Zhou X; Wang Q
Mol Vis; 2017; 23():538-547. PubMed ID: 28761327
[TBL] [Abstract][Full Text] [Related]
3. Upregulated IRAK1 and IRAK4 promoting the production of IFN-γ and IL-17 in Behcet's disease.
Sun M; Yang P; Yang Y; Ye J
Int Ophthalmol; 2018 Oct; 38(5):1947-1953. PubMed ID: 28780618
[TBL] [Abstract][Full Text] [Related]
4. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
Chi W; Yang P; Li B; Wu C; Jin H; Zhu X; Chen L; Zhou H; Huang X; Kijlstra A
J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.
Li F; Yang P; Liu X; Wang C; Hou S; Kijlstra A
Arch Ophthalmol; 2010 Nov; 128(11):1449-54. PubMed ID: 21060047
[TBL] [Abstract][Full Text] [Related]
6. Increased IL-7 expression in Vogt-Koyanagi-Harada disease.
Yang Y; Xiao X; Li F; Du L; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):1012-7. PubMed ID: 22247488
[TBL] [Abstract][Full Text] [Related]
7. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.
Chu M; Yang P; Hu R; Hou S; Li F; Chen Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7084-9. PubMed ID: 21810982
[TBL] [Abstract][Full Text] [Related]
9. Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
Yi X; Yang P; Sun M; Yang Y; Li F
Mol Vis; 2011 Mar; 17():673-9. PubMed ID: 21403851
[TBL] [Abstract][Full Text] [Related]
10. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.
Wang C; Tian Y; Lei B; Xiao X; Ye Z; Li F; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4668-75. PubMed ID: 22669715
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of IL-23 Receptor (IL-23R) in Vogt-Koyanagi-Harada (VKH) Disease.
Wang C; Wang L; Hu J; Li H; Kijlstra A; Yang P
Curr Eye Res; 2018 Nov; 43(11):1369-1373. PubMed ID: 29877734
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease.
He Y; Wang C; Su G; Deng B; Ye Z; Huang Y; Yuan G; Aize K; Li H; Yang P
Br J Ophthalmol; 2018 Aug; 102(8):1167-1172. PubMed ID: 29699987
[TBL] [Abstract][Full Text] [Related]
13. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease.
Imai Y; Sugita M; Nakamura S; Toriyama S; Ohno S
Curr Eye Res; 2001 Apr; 22(4):312-8. PubMed ID: 11462171
[TBL] [Abstract][Full Text] [Related]
14. Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment.
Ye Z; Wang C; Tang J; Zhou Y; Bai L; Liu Y; Kijlstra A; Yang P
J Interferon Cytokine Res; 2015 Apr; 35(4):265-72. PubMed ID: 25343528
[TBL] [Abstract][Full Text] [Related]
15. Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease.
Yang J; Hu J; Feng L; Yi S; Ye Z; Lin M; Liu X; Pu Y; Kijlstra A; Yang P; Li H
Ocul Immunol Inflamm; 2020; 28(2):200-208. PubMed ID: 30794473
[No Abstract] [Full Text] [Related]
16. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
17. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
Commodaro AG; Peron JP; Genre J; Arslanian C; Sanches L; Muccioli C; Rizzo LV; Belfort R
Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
[TBL] [Abstract][Full Text] [Related]
18. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion.
Liu L; Yang P; He H; Lin X; Jiang L; Chi W; Zhao C; Zhou H
Br J Ophthalmol; 2008 Apr; 92(4):557-61. PubMed ID: 18245271
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.
Xu M; Wang C; Tian Y; Kijlstra A; Yang P
Ocul Immunol Inflamm; 2014 Aug; 22(4):294-9. PubMed ID: 24329541
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease.
Chang R; Yi S; Tan X; Huang Y; Wang Q; Su G; Zhou C; Cao Q; Yuan G; Kijlstra A; Yang P
Br J Ophthalmol; 2018 Feb; 102(2):282-290. PubMed ID: 28972028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
